Patricia holds her Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She also served as a PhD student research assistant in the Laboratory of Doctor David A. Fidock, Department of Microbiology & Immunology, Columbia University, New York.
Uveitis, a form of eye inflammation, worsens vision and vision-related quality of life among children with juvenile idiopathic arthritis (JIA), according ... Read more
A localized injection of corticosteroids into the temporomandibular joints (TMJs) — the joints near the ears where the jawbone connects to ... Read more
Treatment with Ilaris (canakinumab) at doses lower than the one recommended might be enough to maintain clinical remission in people with systemic ... Read more
The European Commission has approved Nepexto, a biosimilar of Enbrel (etanercept), for the treatment of juvenile idiopathic arthritis and other inflammatory disorders. Nepexto is expected ... Read more
Close to one-fifth of infections in children with juvenile idiopathic arthritis (JIA) on immunosuppressants are caused by opportunistic pathogens — such ... Read more
The U.S. Food and Drug Administration (FDA) has approved RediTrex, an injectable form of methotrexate, for the treatment of juvenile idiopathic ... Read more
Nearly 60% of respondents in a national survey of people with juvenile arthritis and other rheumatic diseases reported struggling to afford ... Read more
Blood levels of chemokines CXCL8 and CXCL10 — two signalling molecules— may help predict risk for juvenile idiopathic arthritis and rheumatoid ... Read more
